summary
Introduced
03/28/2019
03/28/2019
In Committee
03/28/2019
03/28/2019
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
Requires the Government Accountability Office to complete a study reviewing how federal agencies address barriers to participation in federally-funded cancer clinical trials by individuals from underrepresented populations and provide recommendations for addressing such barriers.
AI Summary
This bill, the Henrietta Lacks Enhancing Cancer Research Act of 2019, requires the Government Accountability Office (GAO) to conduct a study reviewing the actions federal agencies have taken to address barriers to participation in federally-funded cancer clinical trials by populations that have been traditionally underrepresented, such as racial and ethnic minorities, older individuals, and those from rural or lower-income areas. The study will also identify additional actions that can be taken to address these barriers and provide recommendations to Congress on potential changes in practices and policies to improve participation in such trials by these populations. The bill aims to build on the legacy of Henrietta Lacks, an African-American woman whose cancer cells, without her consent, made significant contributions to medical research and advancements.
Committee Categories
Health and Social Services
Sponsors (8)
Chris Van Hollen (D)*,
Ben Cardin (D),
Susan Collins (R),
Kirsten Gillibrand (D),
Doug Jones (D),
Tina Smith (D),
Jon Tester (D),
Sheldon Whitehouse (D),
Last Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 03/28/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/116th-congress/senate-bill/946/all-info |
| BillText | https://www.congress.gov/116/bills/s946/BILLS-116s946is.pdf |
| Bill | https://www.congress.gov/116/bills/s946/BILLS-116s946is.pdf.pdf |
Loading...